C

Cannabis Poland SA
WSE:CBD

Watchlist Manager
Cannabis Poland SA
WSE:CBD
Watchlist
Price: 0.3565 PLN 2%
Market Cap: 17.5m PLN

Intrinsic Value

CBD's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CBD stock under the Base Case scenario is 0.0152 PLN. Compared to the current market price of 0.3565 PLN, Cannabis Poland SA is Overvalued by 96%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CBD Intrinsic Value
0.0152 PLN
Overvaluation 96%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Cannabis Poland SA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
CBD
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CBD cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Cannabis Poland SA
WSE:CBD
PL
Pharmaceuticals
Market Cap
17.5m PLN
IPO
Apr 9, 2013
PL
Pharmaceuticals
Market Cap
17.5m PLN
IPO
Apr 9, 2013
Price
złfalse
EPS
złfalse
Company Overview
Loading...
Contacts
Loading...
How do you feel about CBD?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cannabis Poland SA
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Cannabis Poland SA

Balance Sheet Decomposition
Cannabis Poland SA

Current Assets 4.7m
Cash & Short-Term Investments 4.3m
Receivables 272.5k
Other Current Assets 107.7k
Non-Current Assets 372.4k
PP&E 271k
Other Non-Current Assets 101.4k
Efficiency

Free Cash Flow Analysis
Cannabis Poland SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cannabis Poland SA

Revenue
287.8k PLN
Cost of Revenue
-190.7k PLN
Gross Profit
97.1k PLN
Operating Expenses
-2.2m PLN
Operating Income
-2.1m PLN
Other Expenses
136.5k PLN
Net Income
-2m PLN
Fundamental Scores

CBD Profitability Score
Profitability Due Diligence

Cannabis Poland SA's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

15/100
Profitability
Score

Cannabis Poland SA's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

CBD Solvency Score
Solvency Due Diligence

Cannabis Poland SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Cannabis Poland SA's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CBD Price Targets Summary
Cannabis Poland SA

There are no price targets for CBD.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Cannabis Poland SA
does not pay dividends
Shareholder Yield

Current shareholder yield for CBD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one CBD stock?

The intrinsic value of one CBD stock under the Base Case scenario is 0.0152 PLN.

Is CBD stock undervalued or overvalued?

Compared to the current market price of 0.3565 PLN, Cannabis Poland SA is Overvalued by 96%.

Back to Top